Finally, although we lacked survival data in the AHSB or FIVO cohorts, analysis of the METABRIC data revealed a strong correlation between higher RRAS2 expression in breast tumors and shorter overall survival after diagnosis (Fig. 6e). This evidence concerns the gene RRAS2 and breast neoplasm.